Cite
MLA Citation
Ruben Mesa et al.. “The efficacy and safety of continued hydroxycarbamide therapy versus switching to ruxolitinib in patients with polycythaemia vera: a randomized, double‐blind, double‐dummy, symptom study (RELIEF).” British journal of haematology, vol. 176, 2017, pp. 76–85. http://access.bl.uk/ark:/81055/vdc_100039704296.0x000023